Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction
TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over $100M by issuing 8...
Sculptor Xu Hongfei × Dance Troupe of the Fine Arts Department of the Culture Ministry of Thailand
GUANGZHOU, China, Dec. 15, 2023 /PRNewswire/ -- A report from GDToday: Sculpture is a stop-motion dance. December 16 is the International Day of the...
World War Children Care Foundation (WCCF) Launched International Humanitarian Mission to Aid Children Affected by Conflict
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 15 December 2023 - The World War Children Care Foundation (WCCF) officially commenced its...
Steak House Specially Launched 2 Christmas Party Packages
Recommendations: French Feast with Premium Caviar, and A5 Wagyu Beef SukiyakiHONG KONG - Media OutReach Newswire - 16 December 2023 - Steak...
Lufax Announces Receipt of Notice Regarding NYSE Continued Listing Standards and Effectiveness of its ADS Ratio Change
SHANGHAI, Dec. 16, 2023 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for...
Scienjoy Holding Corporation Reports Nine months ended September 30, 2023 Unaudited Financial Results
BEIJING, Dec. 16, 2023 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market,...
Appointment of New Independent Director
NEW YORK, Dec. 16, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company...
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany, Dec....
